Annual Total Liabilities
$2.51 B
-$378.34 M-13.08%
December 31, 2023
Summary
- As of February 26, 2025, NVAX annual total liabilities is $2.51 billion, with the most recent change of -$378.34 million (-13.08%) on December 31, 2023.
- During the last 3 years, NVAX annual total liabilities has risen by +$1.56 billion (+163.22%).
- NVAX annual total liabilities is now -14.14% below its all-time high of $2.93 billion, reached on December 31, 2021.
Performance
NVAX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.24 B
-$11.43 M-0.51%
September 30, 2024
Summary
- As of February 26, 2025, NVAX quarterly total liabilities is $2.24 billion, with the most recent change of -$11.43 million (-0.51%) on September 30, 2024.
- Over the past year, NVAX quarterly total liabilities has dropped by -$96.59 million (-4.14%).
- NVAX quarterly total liabilities is now -26.35% below its all-time high of $3.04 billion, reached on June 30, 2022.
Performance
NVAX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NVAX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.1% | -4.1% |
| 3 y3 years | +163.2% | -23.6% |
| 5 y5 years | +568.9% | +536.0% |
NVAX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | at low | -26.4% | +0.8% |
| 5 y | 5-year | -14.1% | +600.5% | -26.4% | +536.0% |
| alltime | all time | -14.1% | >+9999.0% | -26.4% | >+9999.0% |
Novavax Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.24 B(-0.5%) |
| Jun 2024 | - | $2.25 B(+1.3%) |
| Mar 2024 | - | $2.22 B(-11.7%) |
| Dec 2023 | $2.51 B(-13.1%) | $2.51 B(+7.7%) |
| Sep 2023 | - | $2.34 B(-4.3%) |
| Jun 2023 | - | $2.44 B(+0.1%) |
| Mar 2023 | - | $2.44 B(-15.7%) |
| Dec 2022 | $2.89 B(-1.2%) | $2.89 B(+2.1%) |
| Sep 2022 | - | $2.83 B(-6.8%) |
| Jun 2022 | - | $3.04 B(+9.8%) |
| Mar 2022 | - | $2.77 B(-5.4%) |
| Dec 2021 | $2.93 B(+206.6%) | $2.93 B(+39.1%) |
| Sep 2021 | - | $2.10 B(+5.0%) |
| Jun 2021 | - | $2.00 B(+27.7%) |
| Mar 2021 | - | $1.57 B(+64.3%) |
| Dec 2020 | $955.27 M(+166.1%) | $955.27 M(+14.1%) |
| Sep 2020 | - | $837.58 M(+12.0%) |
| Jun 2020 | - | $747.70 M(+112.4%) |
| Mar 2020 | - | $352.04 M(-1.9%) |
| Dec 2019 | $358.97 M(-4.5%) | $358.97 M(+1.2%) |
| Sep 2019 | - | $354.65 M(-5.4%) |
| Jun 2019 | - | $374.88 M(+0.8%) |
| Mar 2019 | - | $371.90 M(-1.1%) |
| Dec 2018 | $375.91 M(-7.0%) | $375.91 M(-0.3%) |
| Sep 2018 | - | $377.16 M(+1.0%) |
| Jun 2018 | - | $373.51 M(-0.5%) |
| Mar 2018 | - | $375.44 M(-7.1%) |
| Dec 2017 | $404.23 M(+1.1%) | $404.23 M(-1.0%) |
| Sep 2017 | - | $408.23 M(-1.6%) |
| Jun 2017 | - | $414.77 M(+6.2%) |
| Mar 2017 | - | $390.60 M(-2.3%) |
| Dec 2016 | $399.85 M(+328.2%) | $399.85 M(-2.4%) |
| Sep 2016 | - | $409.84 M(-1.2%) |
| Jun 2016 | - | $414.89 M(+1.9%) |
| Mar 2016 | - | $407.07 M(+336.0%) |
| Dec 2015 | $93.37 M(+101.3%) | $93.37 M(+148.2%) |
| Sep 2015 | - | $37.62 M(+1.4%) |
| Jun 2015 | - | $37.09 M(-5.2%) |
| Mar 2015 | - | $39.13 M(-15.6%) |
| Dec 2014 | $46.38 M(+45.4%) | $46.38 M(+50.3%) |
| Sep 2014 | - | $30.86 M(+2.0%) |
| Jun 2014 | - | $30.26 M(+9.9%) |
| Mar 2014 | - | $27.54 M(-13.6%) |
| Dec 2013 | $31.89 M(+44.3%) | $31.89 M(+11.9%) |
| Sep 2013 | - | $28.50 M(+20.3%) |
| Jun 2013 | - | $23.69 M(+12.1%) |
| Mar 2013 | - | $21.14 M(-4.4%) |
| Dec 2012 | $22.11 M(+73.7%) | $22.11 M(+15.3%) |
| Sep 2012 | - | $19.17 M(+20.6%) |
| Jun 2012 | - | $15.90 M(+11.1%) |
| Mar 2012 | - | $14.31 M(+12.5%) |
| Dec 2011 | $12.73 M(-19.4%) | $12.73 M(+1.9%) |
| Sep 2011 | - | $12.49 M(-4.5%) |
| Jun 2011 | - | $13.07 M(-21.3%) |
| Mar 2011 | - | $16.61 M(+5.1%) |
| Dec 2010 | $15.79 M | $15.79 M(+28.2%) |
| Sep 2010 | - | $12.32 M(+7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $11.42 M(-6.7%) |
| Mar 2010 | - | $12.24 M(-21.8%) |
| Dec 2009 | $15.65 M(-49.7%) | $15.65 M(+76.6%) |
| Sep 2009 | - | $8.86 M(-34.3%) |
| Jun 2009 | - | $13.50 M(-55.3%) |
| Mar 2009 | - | $30.17 M(-3.1%) |
| Dec 2008 | $31.14 M(+10.3%) | $31.14 M(-6.7%) |
| Sep 2008 | - | $33.39 M(-0.5%) |
| Jun 2008 | - | $33.56 M(+10.3%) |
| Mar 2008 | - | $30.43 M(+7.8%) |
| Dec 2007 | $28.23 M(+1.3%) | $28.23 M(+1.4%) |
| Sep 2007 | - | $27.82 M(+0.2%) |
| Jun 2007 | - | $27.78 M(-1.8%) |
| Mar 2007 | - | $28.28 M(+1.4%) |
| Dec 2006 | $27.88 M(-19.7%) | $27.88 M(+6.2%) |
| Sep 2006 | - | $26.24 M(-1.9%) |
| Jun 2006 | - | $26.75 M(+1.6%) |
| Mar 2006 | - | $26.33 M(-24.2%) |
| Dec 2005 | $34.73 M(-22.3%) | $34.73 M(-14.6%) |
| Sep 2005 | - | $40.64 M(-2.3%) |
| Jun 2005 | - | $41.60 M(-1.4%) |
| Mar 2005 | - | $42.18 M(-5.7%) |
| Dec 2004 | $44.71 M(-7.3%) | $44.71 M(+1.5%) |
| Sep 2004 | - | $44.06 M(-14.1%) |
| Jun 2004 | - | $51.28 M(+6.7%) |
| Mar 2004 | - | $48.05 M(-0.3%) |
| Dec 2003 | $48.22 M(-2.5%) | $48.22 M(-1.1%) |
| Sep 2003 | - | $48.73 M(+2.0%) |
| Jun 2003 | - | $47.79 M(-1.1%) |
| Mar 2003 | - | $48.34 M(-2.2%) |
| Dec 2002 | $49.43 M(+24.8%) | $49.43 M(+0.5%) |
| Sep 2002 | - | $49.19 M(-2.2%) |
| Jun 2002 | - | $50.27 M(+26.1%) |
| Mar 2002 | - | $39.86 M(+0.6%) |
| Dec 2001 | $39.62 M(+60.4%) | $39.62 M(+2.0%) |
| Sep 2001 | - | $38.83 M(+38.2%) |
| Jun 2001 | - | $28.10 M(+16.8%) |
| Mar 2001 | - | $24.06 M(-2.6%) |
| Dec 2000 | $24.70 M(+1353.2%) | $24.70 M(+1118.8%) |
| Sep 2000 | - | $2.03 M(+18.3%) |
| Jun 2000 | - | $1.71 M(+21.9%) |
| Mar 2000 | - | $1.41 M(-17.3%) |
| Dec 1999 | $1.70 M(+112.5%) | $1.70 M(+70.0%) |
| Sep 1999 | - | $1.00 M(+233.3%) |
| Jun 1999 | - | $300.00 K(-66.7%) |
| Mar 1999 | - | $900.00 K(+12.5%) |
| Dec 1998 | $800.00 K(+166.7%) | $800.00 K(+300.0%) |
| Sep 1998 | - | $200.00 K(-33.3%) |
| Jun 1998 | - | $300.00 K(0.0%) |
| Mar 1998 | - | $300.00 K(0.0%) |
| Dec 1997 | $300.00 K(-50.0%) | $300.00 K(+50.0%) |
| Sep 1997 | - | $200.00 K(-60.0%) |
| Jun 1997 | - | $500.00 K(+25.0%) |
| Mar 1997 | - | $400.00 K(-33.3%) |
| Dec 1996 | $600.00 K | $600.00 K(+50.0%) |
| Sep 1996 | - | $400.00 K(-20.0%) |
| Jun 1996 | - | $500.00 K(0.0%) |
| Mar 1996 | - | $500.00 K |
FAQ
- What is Novavax annual total liabilities?
- What is the all time high annual total liabilities for Novavax?
- What is Novavax annual total liabilities year-on-year change?
- What is Novavax quarterly total liabilities?
- What is the all time high quarterly total liabilities for Novavax?
- What is Novavax quarterly total liabilities year-on-year change?
What is Novavax annual total liabilities?
The current annual total liabilities of NVAX is $2.51 B
What is the all time high annual total liabilities for Novavax?
Novavax all-time high annual total liabilities is $2.93 B
What is Novavax annual total liabilities year-on-year change?
Over the past year, NVAX annual total liabilities has changed by -$378.34 M (-13.08%)
What is Novavax quarterly total liabilities?
The current quarterly total liabilities of NVAX is $2.24 B
What is the all time high quarterly total liabilities for Novavax?
Novavax all-time high quarterly total liabilities is $3.04 B
What is Novavax quarterly total liabilities year-on-year change?
Over the past year, NVAX quarterly total liabilities has changed by -$96.59 M (-4.14%)